Dr. Giannarelli is an Associate Professor of Cardiology, Medicine and Associate Professor of Pathology at the New York University (NYU) Langone Health and the NYU Grossman School of Medicine in New York City. She is a physician scientist with years of experience in the field of vascular biology and atherosclerosis. She has published original research spanning from preclinical models to clinical studies in the areas of endothelial dysfunction, arterial stiffness, hypertension, angiogenesis, and atherosclerosis. Dr. Giannarelli currently focuses on translational and patient-oriented research using systems biology and drug repurposing approaches. Her laboratory was the first to integrate Cytometry by time of flight (CyTOF), single cell RNA sequencing (scRNAseq), and Cellular Indexing of Transcriptomes and Epitopes by sequencing (CITE-Seq) to map the composition and molecular states of circulating and plaque-derived immune cells from CVD patients and to establish their role in plaque progression and clinical cardiovascular events.

Henry Ginsberg is the Irving Professor of Medicine at the Columbia University Medical Center, New York. His research interests have centered on regulation of the metabolism of apolipoprotein B containing lipoproteins, including very low density lipoproteins, low density lipoproteins, and lipoprotein (a), in cells, mice and humans. He has published over 400 peer-reviewed and invited papers in journals such as Science Translational Medicine, the JCI, Circulation, Nature Medicine, Cell Metabolism, and JAMA. Most recently he added studies of the regulation of hepatic lipid homeostasis and NAFLD to his research interests. Dr. Ginsberg has also been involved in many major clinical trials, including ACCORD Lipid, where he was the lead investigator. He has been Co-Chair of the European Atherosclerosis Society Consensus Panel that has published major papers in the European Heart Journal during the past decade. He has received funding from the NIH for more than 40 years and has collected numerous awards from the American Heart Association (AHA) and the American Diabetes Association (ADA). In 2017, Dr. Ginsberg received an Outstanding Investigator Award from the NIH/NHLBI providing $4 million in support over 7 years. In addition to his research and training activities, Dr. Ginsberg sees patients with severe lipid disorders.

Zivile Girkantaite is a Resident Doctor in Cardiology at Vilnius University Hospital Santaros Klinikos. In 2020, she completed the integrated study program in Medicine and has been awarded a Master’s degree in Medicine from Vilnius University with honors, magna cum laude, and the qualification of Medical Doctor. In her medical research, she focuses on cardiovascular prevention, cardiovascular risk factors, endothelial function, and vascular aging. Zivile has published two articles related to her area of interest and a third article is currently under submission. She has given oral presentations at different International Medical Congresses for Young Scientists in 2018, 2019, and 2020.

Émilie left her little village in Lac-Saint-Jean to obtain her bachelor's degree in biomedical sciences at Laval University in 2021. During her undergraduate university studies, she had the opportunity to complete two internships with Dr. Benoît Arsenault's team. She began her master's degree in clinical and biomedical sciences in May 2021 by being a scholarship holder of the Fonds de recherche du Québec: Santé (FRQS). IShe is specialized in Mendelian randomization studies and her research objective is to identify therapeutic targets or biomarkers for non-alcoholic fatty liver disease to prevent NASH and its complications using human genetics.

Anne Carol Goldberg, MD, FACP, FAHA, FNLA is an endocrinologist and lipid specialist. She received her medical degree from University of Maryland and completed internal medicine residency at Michael Reese Hospital, Chicago, Illinois, and endocrinology fellowship at Washington University School of Medicine, St. Louis, Missouri, where she is now Professor of Medicine. Research interests include therapies for hyperlipidemia and the treatment of familial hypercholesterolemia. She has conducted clinical trials involving most classes of lipid-modifying drugs. She treats adults and children with dyslipidemia, including familial hypercholesterolemia, and has a lipoprotein apheresis program. Awards include the National Forum for Heart Disease and Stroke Prevention Public Policy Award, the Foundation of the National Lipid Association Clinician/Educator Award, and Washington University School of Medicine Distinguished Clinician Award. She is a past President of the National Lipid Association (NLA) and immediate past president of the Foundation of the NLA. She chaired the NLA Expert Panel on Familial Hypercholesterolemia and was a member of the ACC/AHA Blood Cholesterol Expert Panel for the 2013 ACC/AHA Cholesterol Guidelines and of the task force for the Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Hypertriglyceridemia. She is currently the Chief Science Officer of the NLA.

Dr. Goldberg received his undergraduate degree from MIT and his medical degree from Harvard Medical School. After fellowships in endocrinology and metabolism, and atherosclerosis and metabolism, he was appointed to the faculty of the Department of Medicine at Columbia University in 1983 and was Chief of the Division of Preventive Medicine and Nutrition and the Dickinson Richards Professor of Medicine. He is currently the Clarissa and Edgar Bronfman, Jr. Professor and Chief of the Division of Endocrinology, Diabetes and Metabolism at New York University School of Medicine. Dr. Goldberg has published over 200 articles, as well as numerous book chapters, editorials, and reviews. His research has focused on abnormalities of lipoprotein metabolism, macrovascular disease in diabetes, and the role of triglycerides in atherosclerosis. Among Dr. Goldberg’s honors is a MERIT Award from the National Heart, Lung, and Blood Institute. He was chosen to give the 2007 Robert Levy Lecture of the NPAM Committee of the American Heart Association, the Edwin Bierman Lecture on diabetes and heart disease at the 2010 American Diabetes Association Meeting, and the 2017 George Lyman Duff Lecture of the ATVB council.

Doctor of medical sciences, cardiovascular surgeon, interventional radiologist, expert of clinical management, associate professor of cardiology, interventional and hybrid technology of the Medical Institute Russian University of Peoples' Friendship. In 2012–2015 chief specialist of the Ministry of Health of the Moscow Region for interventional radiology, has experience in organizing endovascular care in federal, private and municipal medical organizations, the author of three patents and more than 120 scientific and methodical publications of SCOPUS, WoS and other. Author of monography "ORGANIZATIONAL AND CLINICAL BASES OF ENDOVASCULAR CARE FOR CARDIOVASCULAR DISEASES" and tutorial "Clinical and organizational management of endovascular care".

Dr. Antonio M. Gotto is Dean Emeritus and Provost for Medical Affairs Emeritus of Weill Cornell Medical College. Previously, at Baylor College of Medicine in Houston, Texas, he was the Bob and Vivian Smith Professor and Chairman of the Department of Medicine, Scientific Director of the DeBakey Heart Center, and the JS Abercrombie Chair for Atherosclerosis and Lipoprotein Research. He also served as Chief of the Internal Medicine Service at The Methodist Hospital in Houston. Dr. Gotto's postgraduate work included doctoral studies at Oxford University in England as a Rhodes Scholar, and residency training at the Massachusetts General Hospital in Boston, Massachusetts. As a lifelong supporter of educational efforts aimed at cardiovascular risk reduction, Dr. Gotto has been National President of the American Heart Association, President of the International Atherosclerosis Society, and National Lipid Association. He is a member of the Institute of Medicine and the American Academy of Arts and Sciences and a recipient of many honors, including the Gold Heart Award from the American Heart Association, the 2000 Distinguished Alumnus award from Vanderbilt University and the Vanderbilt University School of Medicine, honorary doctoral degrees from the University of Bologna and Abilene Christian University, honorary professorships from the University of Buenos Aires and Francisco Marroquin University (Guatemala), and the Order of the Lion from the Republic of Finland. Dr. Gotto was the 2004 recipient of the International Okamoto Award from the Japan Vascular Disease Research Foundation. In 2004 Dr. Gotto was also named Honorary Member of the Society for Progress in Internal Medicine (Ludwig Heilmeyer Society) in Germany. In 2010, he received the Maurice R. Greenberg Distinguished Service Award, the highest honor bestowed by New York-Presbyterian/Weill Cornell on members of the medical staff.